Amazing how nobody here seems to know about the competitors in the HAE market. Please, inform yourself before you think this stock is a 10-bagger as some pumpers here argue. Wake up, Dyax is far behind Pharming as far as the HAE application is concerned. Just read this:
Pharming at this time does not currently have a clinical trial going in the United States for Hereditary Angioedema. The way our FDA is here in the States, It will be a long time before they are as far along as Dyax/Genzyme are for treating us with this disorder.
This is just a bump in the road, Dyax/Genzyme have a great treatment that works quickly and has to date caused no problems when administered to Humans.